Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Trueperella bernardiae

ABSTRACT: Whole genome sequencing of Arcanobacterium bernardiae, an opportunistic pathogen

PROVIDER: PRJDB2106 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR015937_1.fastq.gz	Fastqsanger.gz
	DRR015937_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Trueperella bernardiae

Project description:Whole genome sequencing of Arcanobacterium bernardiae, an opportunistic pathogen

| PRJDB2333 | ENA

Trueperella bernardiae

Project description:Whole genome sequencing of Arcanobacterium bernardiae, an opportunistic pathogen

| PRJDB2516 | ENA

Trueperella bernardiae

Project description:Trueperella bernardiae overview

| PRJNA247706 | ENA

Trueperella bernardiae strain:LND_65A18

Project description:Trueperella bernardiae strain:LND_65A18 Genome sequencing and assembly

| PRJNA291432 | ENA

Trueperella pyogenes

Project description:Whole genome sequencing of Trueperella pyogenes, an opportunistic pathogen

| PRJDB2237 | ENA

Trueperella bernardiae strain:LCDC 89-0504

Project description:Draft genome sequence of the type strain of Trueperella bernardiae LCDC 89-0504T

| PRJNA299323 | ENA

Arcanobacterium phocae

Project description:Whole genome sequencing of Arcanobacterium phocae, an opportunistic pathogen

| PRJDB2275 | ENA

Arcanobacterium haemolyticum

Project description:Whole genome sequencing of Arcanobacterium haemolyticum, an opportunistic pathogen

| PRJDB1966 | ENA

First Case of <i>Trueperella bernardiae</i> Bacteremia in an Immunocompromised Patient in Korea.

Project description: Not available

| S-EPMC6660332 | biostudies-literature

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data